Myocardin-related Transcription Factors and SRF Are Required for Cytoskeletal Dynamics and Experimental Metastasis

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2009 Feb 10

PMID 19198601

Citations 237

Authors

Souhila Medjkane

Cristina Perez-Sanchez

Cedric Gaggioli

Erik Sahai

Richard Treisman

Affiliations

Soon will be listed here.

Abstract

Rho GTPases control cytoskeletal dynamics through cytoplasmic effectors and regulate transcriptional activation through myocardin-related transcription factors (MRTFs), which are co-activators for serum response factor (SRF). We used RNA interference to investigate the contribution of the MRTF-SRF pathway to cytoskeletal dynamics in MDA-MB-231 breast carcinoma and B16F2 melanoma cells, in which basal MRTF-SRF activity is Rho-dependent. Depletion of MRTFs or SRF reduced cell adhesion, spreading, invasion and motility in culture, without affecting proliferation or inducing apoptosis. MRTF-depleted tumour cell xenografts showed reduced cell motility but proliferated normally. Tumour cells depleted of MRTF or SRF failed to colonize the lung from the bloodstream, being unable to persist after their arrival in the lung. Only a few genes show MRTF-dependent expression in both cell lines. Two of these, MYH9 (NMHCIIa) and MYL9 (MLC2), are also required for invasion and lung colonization. Conversely, expression of activated MAL/MRTF-A increases lung colonization by poorly metastatic B16F0 cells. Actin-based cell behaviour and experimental metastasis thus require Rho-dependent nuclear signalling through the MRTF-SRF network.

Citing Articles

Essential Role of Cortactin in Myogenic Differentiation: Regulating Actin Dynamics and Myocardin-Related Transcription Factor A-Serum Response Factor (MRTFA-SRF) Signaling.

Ly Q, Nguyen M, Ngo T, Lee W Int J Mol Sci. 2025; 25(24.

PMID: 39769327 PMC: 11677934. DOI: 10.3390/ijms252413564.

Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner.

Chawla P, Sharma I, Gau D, Eder I, Chen F, Yu V Mol Biol Cell. 2024; 36(1):ar8.

PMID: 39630611 PMC: 11742114. DOI: 10.1091/mbc.E24-06-0285.

Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer.

Panesso-Gomez S, Cole A, Wield A, Anyaeche V, Shah J, Jiang Q bioRxiv. 2024; .

PMID: 39605642 PMC: 11601311. DOI: 10.1101/2024.11.15.623825.

New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms.

Wong D, Qiu H Vascul Pharmacol. 2024; 157():107443.

PMID: 39586415 PMC: 11648470. DOI: 10.1016/j.vph.2024.107443.

Functional gene signature offers a powerful tool for characterizing clinicopathological features and depicting tumor immune microenvironment of colorectal cancer.

Zhu Z, Li J, Fa Z, Xu X, Wang Y, Zhou J BMC Cancer. 2024; 24(1):1199.

PMID: 39342165 PMC: 11437988. DOI: 10.1186/s12885-024-12996-y.

References

Goulimari P, Kitzing T, Knieling H, Brandt D, Offermanns S, Grosse R . Galpha12/13 is essential for directed cell migration and localized Rho-Dia1 function. J Biol Chem. 2005; 280(51):42242-51. DOI: 10.1074/jbc.M508690200. View

Jiang W, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel R . Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004; 11(4):781-91. DOI: 10.1677/erc.1.00825. View

Somlyo A, Somlyo A . Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003; 83(4):1325-58. DOI: 10.1152/physrev.00023.2003. View

van Golen K, Davies S, Wu Z, Wang Y, Bucana C, Root H . A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res. 1999; 5(9):2511-9. View

Bhowmick N, Neilson E, Moses H . Stromal fibroblasts in cancer initiation and progression. Nature. 2004; 432(7015):332-7. PMC: 3050735. DOI: 10.1038/nature03096. View

Nakajima M, Hayashi K, Egi Y, Katayama K, Amano Y, Uehata M . Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma. Cancer Chemother Pharmacol. 2003; 52(4):319-24. DOI: 10.1007/s00280-003-0641-9. View

Sun Q, Chen G, Streb J, Long X, Yang Y, Stoeckert Jr C . Defining the mammalian CArGome. Genome Res. 2005; 16(2):197-207. PMC: 1361715. DOI: 10.1101/gr.4108706. View

Somogyi K, Rorth P . Evidence for tension-based regulation of Drosophila MAL and SRF during invasive cell migration. Dev Cell. 2004; 7(1):85-93. DOI: 10.1016/j.devcel.2004.05.020. View

Tan W, Martin D, Gutkind J . The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem. 2006; 281(51):39542-9. DOI: 10.1074/jbc.M609062200. View

10.

Dua P, Gude R . Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer. 2008; 44(11):1587-95. DOI: 10.1016/j.ejca.2008.04.009. View

11.

Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

12.

Caceres M, Guerrero J, Martinez J . Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res. 2005; 309(1):229-38. DOI: 10.1016/j.yexcr.2005.05.020. View

13.

Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti M, Segall J . Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med. 2002; 7(12):816-30. PMC: 1950008. View

14.

Dulyaninova N, House R, Betapudi V, Bresnick A . Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. Mol Biol Cell. 2007; 18(8):3144-55. PMC: 1949358. DOI: 10.1091/mbc.e06-11-1056. View

15.

Cen B, Selvaraj A, Burgess R, Hitzler J, Ma Z, Morris S . Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol. 2003; 23(18):6597-608. PMC: 193697. DOI: 10.1128/MCB.23.18.6597-6608.2003. View

16.

Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A . The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol. 2006; 173(3):395-404. PMC: 2063840. DOI: 10.1083/jcb.200510115. View

17.

Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall J, Harrington K . Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007; 9(12):1392-400. DOI: 10.1038/ncb1658. View

18.

Betapudi V, Licate L, Egelhoff T . Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. Cancer Res. 2006; 66(9):4725-33. DOI: 10.1158/0008-5472.CAN-05-4236. View

19.

Yamaguchi H, Condeelis J . Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2006; 1773(5):642-52. PMC: 4266238. DOI: 10.1016/j.bbamcr.2006.07.001. View

20.

Pinner S, Sahai E . PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol. 2008; 10(2):127-37. DOI: 10.1038/ncb1675. View